Atrial Fibrillation Market is expected to reach US$ 18,085.96 Mn in 2027
Published Date : 17/02/2020

Report : Atrial Fibrillation Market to 2027 - Global Analysis and Forecasts By Treatment Type (Non-pharmacological, Pharmacological); End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) and Geography

Non-Pharmacological Segment by Treatment Type Is Expected to Grow at A Fast Pace Over the Forecast Period

 

According to The Insight Partners market research study of 'Atrial Fibrillation Market to 2027 – Global Analysis and Forecasts by Treatment Type and End User'. The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving market along with those that act as hindrances.

 

The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories

 

The Atrial Fibrillation Market for is expected to grow, owing to factors such as increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. Moreover, growth opportunities in the developing nations are likely to have a positive impact on the growth of the market in coming years.

 

Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.

 

Global Atrial Fibrillation Market, By Regions, 2018 (%)
Global Atrial Fibrillation Market, By Regions, 2018 (%)

The report segments Global Atrial Fibrillation Market as follows:

 

Global Atrial Fibrillation Market - By Treatment Type

  • Non - pharmacological
    • MAZE Surgery
    • Catheter Ablation
    • Electric Cardioversion
  • Pharmacological
    • Anti-arrhythmic Drugs
    • Anti-coagulant Drugs

Global Atrial Fibrillation Market - By End User

  • Hospitals
  • Ambulatory Surgical Centers,
  • Cardiac Catheterization Laboratories

Global Atrial Fibrillation Market - By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina

 

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com

 

DOWNLOAD PDF BROCHURE